Key result
MCT1 upregulation marks decompensated heart failure with reduced shortening velocity and severe lung congestion.
Why the study?
It remains to be seen whether MCT1 upregulation is a general feature of end stage heart failure irrespective of cause.
Key points are not available for this paper at this time.
Population
failure rats with decompensated heart failure
Design
Other
Answers are grounded in this paper and cite their sources.
Rat model validates decompensated HF physiology; leaves open whether MCT1 upregulation generalizes across end-stage HF causes.
failure rats were undoubtedly in decompensated failure because, as a consequence of reduced velocity of shortening of the left ventricle and high end diastolic pressure, they had severe lung congestion.However, it remains to be seen whether MCT1 upregulation is a general feature of end stage heart failure irrespective of cause.
No takes yet. Share an insight, caveat, or question.
Houman Ashrafian (2002) studied this question. MCT1 upregulation occurs in rats with decompensated heart failure characterized by reduced left ventricular shortening velocity and severe lung congestion.
Synapse has enriched 10 related papers. Consider them for comparative context: